Skip to main content
Premium Trial:

Request an Annual Quote

Barcelona Genomics Center Buys Genomatix Analyzer

NEW YORK (GenomeWeb News) – A Barcelona biomedical research center focused on genomic studies has bought a Genomatix Genome Analyzer for use in its disease and epigenetics studies, Genomatix said today.

The GGA provides downstream tools and databases for deep biological analysis of mapped data that comes from next generation sequencers, Genomatix said.

The Centre for Genomic Regulation in Barcelona will use the GGA to study the molecular mechanisms underlying breast cancer. It also will use the GGA for a second research program focused on identifying the mechanisms by which the genome is silenced through chromatin modification and small regulatory RNA, said Ramin Shiekhattar, who is group leader of the center's Gene Regulation Programme, in a statement.

The CRG was created by the Catalan Government's Department of Universities, Research and Information Society, the Catalan Department of Health, Pompeu Fabra University, and the Spanish Ministry of Education and Science.

Financial terms of the agreement were not released.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.